MEI Pharma, Inc.·4

Jul 16, 5:33 PM ET

GOLD DANIEL P PHD 4

4 · MEI Pharma, Inc. · Filed Jul 16, 2018

Insider Transaction Report

Form 4
Period: 2018-07-12
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-07-12+300,000300,000 total
    Exercise: $4.28Exp: 2028-07-12Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]One-quarter of such Options shall vest on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION